Tabla de Contenidos:
  • Cover; International Drug Control; Title; Copyright; Dedication; Contents; Figures and maps; Tables and boxes; Preface and acknowledgements; Abbreviations; 1: Introduction; The global drug prohibition regime; On the right path? Differential metrics of success; Approaches and key themes; Plan of the book; 2: Soft defection and the domestic normalization of harm reduction; The mechanics of soft defection: harm reduction via glitches in the system; The domestic normalization of harm reduction; Opioid substitution therapy
  • from law enforcement to public health.
  • Needle and syringe programmes
  • grassroots and government initiativesControlled heroin prescription: long history, limited uptake; Drug consumption rooms: robust legal justification, limited uptake; Harm reduction and policy transfer; 'Condemned to pragmatism': the emergence of harm reduction as a core component of EU drug policy; Maastricht: changing the landscape; Harm reduction via triangulation; The impact of the 2005-08 Action Plan; Concluding discussion; 3: Harm reduction at the UN: member state tension and systemic dissonance.
  • Harm reduction at the CND, 1998-2009: schisms, science and suasionCountry and regional group statements; The dynamics of dissonance: regime (in)stability; Drug control, harm reduction and core UN values; Concluding discussion; 4: Cannabis, soft defection and regime weakening; Cannabis within the conventions: composite classification; First and second waves of soft defection; Prohibition with cautioning or diversion ('depenalization'); Prohibition with civil penalties ('decriminalization'); Medical marijuana control; Partial prohibition: de facto and de jure legalization.
  • Partial prohibition: de facto legalizationPartial prohibition: de jure legalization; Commonalities underpinning soft defection; The issue of cannabis at the CND, 1998-2009; Cannabis resolutions: the INCB and the diligent producer versus the 'lenient' consumer state dichotomy; Cannabis as the 'most vulnerable point in the whole multilateral edifice'; Dronabinol and the WHO; Concluding discussion; 5: Defending the regime: the International Narcotics Control Board; The INCB and its place within the international drug control system; Defence via the Annual Report.
  • Inconsistent positions on policy debatesSelective use of the available evidence base; Selective focus of subject matter; Exceeding mandate; Defence by other means: missions, letters and misuse of expert roles; Coca and the conventions: the hardening of the INCB's prohibitionist stance; Reactions to moves to 'un-schedule' coca; Explaining INCB behaviour during the UNGASS decade; Concluding discussion; 6: Beyond regime weakening? Lessons from the UNGASS decade; Rationales for regime modernization; Treaty reform on technical and scientific grounds: cannabis and coca.